The full name

email@vos.com

A Pancreatic Cancer Organoid-in-Matrix Platform Shows Distinct Sensitivities to T Cell Killing

A Pancreatic Cancer Organoid-in-Matrix Platform Shows Distinct Sensitivities to T Cell Killing

The study addresses the challenges of poor treatment responses in pancreatic ductal adenocarcinoma (PDAC) due to tumor heterogeneity and an immunosuppressive tumor microenvironment (TME). It introduces the InterOMaX model system, a 3D co-culture platform that mimics matrix-dependent cellular crosstalk to investigate T cell responses in PDAC. This system uses a customizable matrix and organoid-in-matrix positioning to co-culture PDAC cells with T cells and stromal cells. By detecting and analyzing PDAC cell populations with varying sensitivity to T cell killing, the platform enables identification and validation of gene candidates for T cell resistance, advancing the understanding of cancer cell-intrinsic resistance phenotypes in PDAC.

Keywords: Pancreatic cancer organoid, T-cell killing, pancreatic ductal adenocarcinoma, tumor microenvironment

Subscribe
to the latest updates in the newsletter

Related Solutions

Organoid Service

  • Disease Modeling
  • Oncology
  • Organoid
Organoid Service

Research service

  • Cosmetics
  • OECD TG
  • Zebrafish
Research service

Technical service

  • Bioinfomatics
  • Holotomography
  • Molecular biology
  • Spatial Biology
Technical service

Next Articles

Connect with Us

By submitting your details, you confirm that you have reviewed and agree with the Lambda Biologics Privacy Policy.